Andrew Lynch
Chief Strategy Officer
Andrew Lynch joined Acadia Healthcare in October 2022 as Chief Strategy Officer, responsible for driving ongoing enterprise-level strategy development as well as the advancement of key innovation initiatives in partnership with the broader executive team.
In his prior role, Mr. Lynch served as Vice President of Home Solutions at Humana, where we oversaw three areas. First, the advancement and performance of key strategic partnerships with >$100M invested, notably in the areas of in-home primary care and in-home acute care. Second, the stand up of new home-centric payment and care models, with focus on value-based care. Third, he oversaw overall strategy and investment prioritization for the $2B Home Solutions business.
Mr. Lynch previously served as Vice President of Healthcare Services Business Development at Humana, where he was responsible for M&A, joint ventures and partnerships. In this role he oversaw the >$500M acquisition of Enclara, the nation’s leading hospice pharmacy/PBM, helped initiate the $925M DomaniRx joint venture with Anthem and SS&C and served as the Home Solutions lead for $250M+ in investments in tech-enabled healthcare startups (Dispatch, Heal and Buoy). His first role at Humana was as Director of Corporate Strategy where he helped lead enterprise-level strategic planning across both payor and provider businesses.
Before joining Humana, Mr. Lynch served as Principal of Strategy and Operations at Google and then at Verily, Google’s earlystage healthcare wing. At Google, he led a global team in the Google Hardware division (phones, wearables and virtual reality) focused on retail sales strategy, business planning and market intelligence. As part of this role, he led end-to-end operations for a $10M market research program across 10 countries. At Verily, Mr. Lynch led portfolio strategy across Verily’s 30+ healthtech bets and developed product and go-to-market strategy for several of these investments.
Mr. Lynch started his career at McKinsey & Company as a strategy consultant where he led engagements at the intersection between payors, providers and employers, including projects focused on healthcare transparency, direct employer-provider contracting and private equity investments.
Mr. Lynch earned a bachelor’s degree with highest honors from the University of Kentucky and a PhD in biomedical engineering from Cambridge University in the United Kingdom. He has made contributions to MIT’s AgeLab and is a guest lecturer at Loyola University.
